BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23084562)

  • 1. HIV seroconversion in a health care worker who underwent postexposure prophylaxis following needlestick injury.
    Borba Brum MC; Dantas Filho FF; Yates ZB; Verçoza Viana MC; Martin Chaves EB; Trindade DM
    Am J Infect Control; 2013 May; 41(5):471-2. PubMed ID: 23084562
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroconversion to HIV-1 following a needlestick injury despite combination post-exposure prophylaxis.
    Hawkins DA; Asboe D; Barlow K; Evans B
    J Infect; 2001 Jul; 43(1):12-5. PubMed ID: 11597149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of needlestick injuries: a house officer who has a needlestick.
    Henderson DK
    JAMA; 2012 Jan; 307(1):75-84. PubMed ID: 22146902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-exposure prophylaxis with a maraviroc-containing regimen after occupational exposure to a multi-resistant HIV-infected source person.
    Méchai F; Quertainmont Y; Sahali S; Delfraissy JF; Ghosn J
    J Med Virol; 2008 Jan; 80(1):9-10. PubMed ID: 18041046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an Intervention to Increase Occupational Postexposure Prophylaxis in Sub-Saharan Africa.
    Courtenay-Quirk C; Selenic D; Lahuerta M; Kassa G; Murrman M; Bock N
    J Assoc Nurses AIDS Care; 2016; 27(5):727-30. PubMed ID: 27425796
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonoccupational HIV post-exposure prophylaxis: a 10-year retrospective analysis.
    Tissot F; Erard V; Dang T; Cavassini M
    HIV Med; 2010 Oct; 11(9):584-92. PubMed ID: 20345883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus postexposure prophylaxis for medical trainees on international rotations.
    Mohan S; Sarfaty S; Hamer DH
    J Travel Med; 2010; 17(4):264-8. PubMed ID: 20636600
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiretroviral prophylaxis after non-occupational exposure to HIV in Abidjan (Cote d'Ivoire)].
    Ehui E; Tanon A; Guié P; Aba T; Toa-Lou C; Kassi A; Ouattara I; Kouakou G; Mossou C; Kakou A; Eholié S; Aoussi E; Bissagnéné E
    Med Mal Infect; 2010 Oct; 40(10):574-81. PubMed ID: 20554137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of HIV postexposure prophylaxis after a work-related needlestick injury.
    Camacho-Ortiz A
    Infect Control Hosp Epidemiol; 2012 Jun; 33(6):646-7. PubMed ID: 22561729
    [No Abstract]   [Full Text] [Related]  

  • 10. Postexposure prophylaxis for HIV.
    Daily JP
    AIDS Clin Care; 1997 Aug; 9(8):59-61, 66. PubMed ID: 11364478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.
    Cardo DM; Culver DH; Ciesielski CA; Srivastava PU; Marcus R; Abiteboul D; Heptonstall J; Ippolito G; Lot F; McKibben PS; Bell DM
    N Engl J Med; 1997 Nov; 337(21):1485-90. PubMed ID: 9366579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV post-exposure prophylaxis: complex issues in health care worker management.
    Ball RT
    J S C Med Assoc; 1996 Oct; 92(10):437-40. PubMed ID: 8990671
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV postexposure prophylaxis: Who should get it?
    Campos-Outcalt D
    J Fam Pract; 2006 Jul; 55(7):600-4. PubMed ID: 16822447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanded postexposure prophylaxis for simultaneous multiple source HIV exposure in a health-care worker.
    Baraboutis IG; Papastamopoulos V; Georgiou O; Samarkos M; Vrionis E; Kotsianopoulou M; Skoutelis AT
    Int J STD AIDS; 2010 Feb; 21(2):147-8. PubMed ID: 20090004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroconversion rate among health care workers exposed to HIV-contaminated body fluids: The University of Pittsburgh 13-year experience.
    Nwaiwu CA; Egro FM; Smith S; Harper JD; Spiess AM
    Am J Infect Control; 2017 Aug; 45(8):896-900. PubMed ID: 28449921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on HIV chemoprophylaxis following exposure.
    Flaxman NA; Reed HS
    J Tenn Dent Assoc; 1997 Oct; 77(4):42-4. PubMed ID: 9520762
    [No Abstract]   [Full Text] [Related]  

  • 17. [Postexposure prophylaxis after HIV exposure. German-Austrian recommendations].
    Brodt HR
    Dtsch Med Wochenschr; 1998 Jun; 123(25-26 Suppl):S2-16. PubMed ID: 9672492
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers.
    Sha BE; Proia LA; Kessler HA
    JAMA; 2000 Dec; 284(21):2723. PubMed ID: 11105176
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical practice. Occupational exposure to HIV in health care settings.
    Gerberding JL
    N Engl J Med; 2003 Feb; 348(9):826-33. PubMed ID: 12606738
    [No Abstract]   [Full Text] [Related]  

  • 20. Knowledge and practice of post-exposure prophylaxis (PEP) against HIV infection among health care providers in a tertiary hospital in Nigeria.
    Owolabi RS; Alabi P; Ajayi S; Daniel O; Ogundiran A; Akande TM; Onafowokan AT
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(3):179-83. PubMed ID: 21511981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.